查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1714525

臨床試驗用品市場－全球產業規模、佔有率、趨勢、機會和預測，按臨床階段、按產品和服務、按治療用途、按最終用戶、按地區和競爭進行細分，2020 年至 2030 年

Clinical Trial Supplies Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Clinical Phase, By Product & Services, By Therapeutic Use, By End User, By Region and Competition, 2020-2030F
出版日期: | 出版商: TechSci Research | 英文 181 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

2024 年全球臨床試驗用品市場價值為 28.1 億美元，預計到 2030 年將達到 43.3 億美元，到 2030 年的複合年成長率為 7.43%。由於全球臨床試驗的數量和複雜性不斷增加，該市場正在經歷持續成長。隨著製藥和生物製藥公司致力於加速新療法的開發，對精簡、可靠和合規的供應鏈的需求也日益加劇。臨床試驗的地理分佈越來越分散，持續時間越來越長，並且受到越來越嚴格的監管要求。這增加了對高效物流、溫控儲存和即時追蹤系統的需求。自適應試驗設計和個人化醫療的採用進一步使供應過程複雜化，促使贊助商尋求具有靈活和可擴展能力的供應合作夥伴。

市場概覽
預測期 2026-2030
2024年市場規模 28.1億美元
2030年市場規模 43.3億美元
2025-2030 年複合年成長率 7.43%
成長最快的領域 心血管疾病
最大的市場 北美洲

影響市場的一個重要趨勢是數位技術在臨床試驗物流中的整合。分散和混合試驗模式的興起正在推動贊助商和合約研究組織 (CRO) 採用直接面向患者 (DTP) 的供應策略，並使用數位工具進行監控、預測和庫存控制。用於需求規劃和資料分析的先進軟體平台的實施有助於減少浪費、提高準確性並支援即時決策。智慧包裝、資料安全區塊鏈和人工智慧驅動的預測等創新正在被用來提高營運效率並確保法規遵循。

關鍵市場促進因素

各治療領域臨床試驗數量不斷增加

主要市場挑戰

管理全球供應鏈的複雜性

主要市場趨勢

供應鏈數位化和即時監控的採用率不斷提高

目錄

第 1 章：產品概述

第2章：研究方法

第3章：執行摘要

第4章：顧客之聲

第5章：全球臨床試驗用品市場展望

  • 市場規模和預測
    • 按價值
  • 市場佔有率和預測
    • 依臨床階段（I期、II期、III期、其他）
    • 按產品和服務（製造、倉儲和分銷、供應鏈管理）
    • 依治療用途（腫瘤學、中樞神經系統疾病、心血管疾病、傳染病、代謝紊亂、其他）
    • 按最終用戶（製藥、生物製劑、醫療器材、其他）
    • 按公司分類（2024）
    • 按地區
  • 市場地圖

第6章：北美臨床試驗用品市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 北美：國家分析
    • 美國
    • 墨西哥
    • 加拿大

第7章：歐洲臨床試驗用品市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 歐洲：國家分析
    • 法國
    • 德國
    • 英國
    • 義大利
    • 西班牙

第8章：亞太臨床試驗用品市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 亞太地區：國家分析
    • 中國
    • 印度
    • 韓國
    • 日本
    • 澳洲

第9章：南美洲臨床試驗用品市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 南美洲：國家分析
    • 巴西
    • 阿根廷
    • 哥倫比亞

第10章：中東和非洲臨床試驗用品市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • MEA：國家分析
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國

第 11 章：市場動態

  • 驅動程式
  • 挑戰

第 12 章：市場趨勢與發展

  • 合併與收購（如有）
  • 產品發布（如有）
  • 最新動態

第 13 章：波特五力分析

  • 產業競爭
  • 新進入者的潛力
  • 供應商的力量
  • 顧客的力量
  • 替代產品的威脅

第 14 章：競爭格局

  • Thermo Fisher Scientific Inc.
  • Almac Group
  • Novo Holdings A/S
  • Marken (UPS)
  • PCI Pharma Services
  • Sharp Services LLC
  • Cencora, Inc.
  • Myonex
  • Parexel International Corporation
  • ICON Plc

第 15 章：策略建議

第16章調查會社について,免責事項

簡介目錄
Product Code: 15860

The Global Clinical Trial Supplies Market was valued at USD 2.81 billion in 2024 and is expected to reach USD 4.33 billion by 2030, growing at a CAGR of 7.43% through 2030. The market is experiencing sustained growth due to the increasing volume and complexity of clinical trials globally. As pharmaceutical and biopharmaceutical companies aim to accelerate the development of new therapies, the demand for streamlined, reliable, and compliant supply chains has intensified. Clinical trials are becoming more geographically dispersed, longer in duration, and subject to stricter regulatory requirements. This increases the need for efficient logistics, temperature-controlled storage, and real-time tracking systems. The adoption of adaptive trial designs and personalized medicine is further complicating the supply process, prompting sponsors to seek supply partners with flexible and scalable capabilities.

Market Overview
Forecast Period2026-2030
Market Size 2024USD 2.81 Billion
Market Size 2030USD 4.33 Billion
CAGR 2025-20307.43%
Fastest Growing SegmentCardiovascular Diseases
Largest MarketNorth America

A significant trend shaping the market is the integration of digital technologies in clinical trial logistics. The rise of decentralized and hybrid trial models is pushing sponsors and contract research organizations (CROs) to adopt direct-to-patient (DTP) supply strategies and employ digital tools for monitoring, forecasting, and inventory control. The implementation of advanced software platforms for demand planning and data analytics is helping reduce waste, improve accuracy, and support real-time decision-making. Innovations like smart packaging, blockchain for data security, and AI-driven forecasting are being leveraged to enhance operational efficiency and ensure regulatory compliance.

Key Market Drivers

Rising Number of Clinical Trials Across Therapeutic Areas

The increasing number of clinical trials across various therapeutic areas is a key driver for the Global Clinical Trial Supplies Market. Pharmaceutical, biotechnology, and medical device companies are expanding their research and development pipelines, leading to a surge in clinical research activities. This growth is fueled by increased investments in drug discovery and innovation, along with the growing prevalence of chronic diseases such as cancer, diabetes, cardiovascular disorders, and autoimmune conditions. As new molecules and biologics enter the clinical stage, the demand for efficient and reliable supply chains becomes critical. Sponsors require specialized logistics and packaging services to support complex trial protocols, manage temperature-sensitive products, and ensure the timely delivery of investigational medicinal products (IMPs) to global trial sites.

According to the World Health Organization's International Clinical Trials Registry Platform (ICTRP), the number of newly recruiting trials has steadily increased, with significant growth in regions such as South-East Asia, especially in India. This upward trend in clinical trial activity necessitates robust clinical trial supply chains to handle the increasing complexity and volume of trials. The rise of decentralized trials and direct-to-patient models has further emphasized the need for innovative supply strategies and cold chain infrastructure.

Key Market Challenges

Complexity in Managing Global Supply Chains

Managing global supply chains in the clinical trial supplies market presents significant logistical challenges. Clinical trials are increasingly conducted across multiple countries, complicating supply chain coordination due to varying timelines, different customs regulations, local language requirements, and multiple vendor engagements. Fluctuations in demand forecasts, unpredictable patient enrollment, and protocol amendments further strain supply planning and inventory management. Maintaining drug stability, ensuring timely delivery of investigational products, and preventing stockouts or wastage require highly responsive and adaptive systems. Specialized cold chain logistics and real-time monitoring become even more critical for temperature-sensitive drugs and biologics. As trials move toward decentralized models with direct-to-patient delivery and remote participation, the supply chain must evolve to remain flexible while maintaining quality and compliance. These challenges often add significant costs to trial budgets.

Key Market Trends

Increased Adoption of Supply Chain Digitalization and Real-Time Monitoring

The adoption of supply chain digitalization and real-time monitoring is transforming the operational landscape of the global clinical trial supplies market. Pharmaceutical sponsors and contract research organizations are prioritizing end-to-end visibility to manage the growing complexities of clinical trials. Digital platforms such as Interactive Response Technology (IRT), cloud-based inventory systems, and IoT-enabled tracking tools are becoming essential in enhancing supply chain responsiveness and transparency. These platforms provide real-time insights into drug availability, temperature control, and shipment progress, enabling supply managers to proactively address issues such as stockouts, wastage, and delays.

Real-time monitoring tools ensure compliance with stringent regulatory requirements by capturing data on temperature excursions, delivery confirmations, and chain-of-custody records. This is especially important for sensitive investigational products like biologics and personalized therapies. Predictive analytics integrated with these digital systems can forecast demand fluctuations and help optimize resupply strategies, improving trial continuity. Sponsors gain greater control, reducing risks and enhancing the patient experience by ensuring timely and reliable delivery of trial materials.

Key Market Players

  • Thermo Fisher Scientific Inc.
  • Almac Group
  • Novo Holdings A/S
  • Marken (UPS)
  • PCI Pharma Services
  • Sharp Services LLC
  • Cencora, Inc.
  • Myonex
  • Parexel International Corporation
  • ICON Plc

Report Scope:

In this report, the Global Clinical Trial Supplies Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Clinical Trial Supplies Market, By Clinical Phase:

  • Phase I
  • Phase II
  • Phase III
  • Others

Clinical Trial Supplies Market, By Product & Services:

  • Manufacturing
  • Storage & Distribution
  • Supply Chain Management

Clinical Trial Supplies Market, By Therapeutic Use:

  • Oncology
  • CNS Diseases
  • Cardiovascular Diseases
  • Infectious Disease
  • Metabolic Disorders
  • Others

Clinical Trial Supplies Market, By End User:

  • Pharmaceutical
  • Biologics
  • Medical Device
  • Others

Clinical Trial Supplies Market, By Region:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Turkey

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Clinical Trial Supplies Market.

Available Customizations:

Global Clinical Trial Supplies Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, and Trends

4. Voice of Customer

5. Global Clinical Trial Supplies Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Clinical Phase (Phase I, Phase II, Phase III, Others)
    • 5.2.2. By Product & Services (Manufacturing, Storage & Distribution, Supply Chain Management)
    • 5.2.3. By Therapeutic Use (Oncology, CNS Diseases, Cardiovascular Diseases, Infectious Disease, Metabolic Disorders, Others)
    • 5.2.4. By End User (Pharmaceutical, Biologics, Medical device, Others)
    • 5.2.5. By Company (2024)
    • 5.2.6. By Region
  • 5.3. Market Map

6. North America Clinical Trial Supplies Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Clinical Phase
    • 6.2.2. By Product & Services
    • 6.2.3. By Therapeutic Use
    • 6.2.4. By End User
    • 6.2.5. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Clinical Trial Supplies Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Clinical Phase
        • 6.3.1.2.2. By Product & Services
        • 6.3.1.2.3. By Therapeutic Use
        • 6.3.1.2.4. By End User
    • 6.3.2. Mexico Clinical Trial Supplies Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Clinical Phase
        • 6.3.2.2.2. By Product & Services
        • 6.3.2.2.3. By Therapeutic Use
        • 6.3.2.2.4. By End User
    • 6.3.3. Canada Clinical Trial Supplies Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Clinical Phase
        • 6.3.3.2.2. By Product & Services
        • 6.3.3.2.3. By Therapeutic Use
        • 6.3.3.2.4. By End User

7. Europe Clinical Trial Supplies Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Clinical Phase
    • 7.2.2. By Product & Services
    • 7.2.3. By Therapeutic Use
    • 7.2.4. By End User
    • 7.2.5. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. France Clinical Trial Supplies Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Clinical Phase
        • 7.3.1.2.2. By Product & Services
        • 7.3.1.2.3. By Therapeutic Use
        • 7.3.1.2.4. By End User
    • 7.3.2. Germany Clinical Trial Supplies Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Clinical Phase
        • 7.3.2.2.2. By Product & Services
        • 7.3.2.2.3. By Therapeutic Use
        • 7.3.2.2.4. By End User
    • 7.3.3. United Kingdom Clinical Trial Supplies Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Clinical Phase
        • 7.3.3.2.2. By Product & Services
        • 7.3.3.2.3. By Therapeutic Use
        • 7.3.3.2.4. By End User
    • 7.3.4. Italy Clinical Trial Supplies Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Clinical Phase
        • 7.3.4.2.2. By Product & Services
        • 7.3.4.2.3. By Therapeutic Use
        • 7.3.4.2.4. By End User
    • 7.3.5. Spain Clinical Trial Supplies Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Clinical Phase
        • 7.3.5.2.2. By Product & Services
        • 7.3.5.2.3. By Therapeutic Use
        • 7.3.5.2.4. By End User

8. Asia-Pacific Clinical Trial Supplies Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Clinical Phase
    • 8.2.2. By Product & Services
    • 8.2.3. By Therapeutic Use
    • 8.2.4. By End User
    • 8.2.5. By Country
  • 8.3. Asia-Pacific: Country Analysis
    • 8.3.1. China Clinical Trial Supplies Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Clinical Phase
        • 8.3.1.2.2. By Product & Services
        • 8.3.1.2.3. By Therapeutic Use
        • 8.3.1.2.4. By End User
    • 8.3.2. India Clinical Trial Supplies Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Clinical Phase
        • 8.3.2.2.2. By Product & Services
        • 8.3.2.2.3. By Therapeutic Use
        • 8.3.2.2.4. By End User
    • 8.3.3. South Korea Clinical Trial Supplies Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Clinical Phase
        • 8.3.3.2.2. By Product & Services
        • 8.3.3.2.3. By Therapeutic Use
        • 8.3.3.2.4. By End User
    • 8.3.4. Japan Clinical Trial Supplies Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Clinical Phase
        • 8.3.4.2.2. By Product & Services
        • 8.3.4.2.3. By Therapeutic Use
        • 8.3.4.2.4. By End User
    • 8.3.5. Australia Clinical Trial Supplies Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Clinical Phase
        • 8.3.5.2.2. By Product & Services
        • 8.3.5.2.3. By Therapeutic Use
        • 8.3.5.2.4. By End User

9. South America Clinical Trial Supplies Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Clinical Phase
    • 9.2.2. By Product & Services
    • 9.2.3. By Therapeutic Use
    • 9.2.4. By End User
    • 9.2.5. By Country
  • 9.3. South America: Country Analysis
    • 9.3.1. Brazil Clinical Trial Supplies Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Clinical Phase
        • 9.3.1.2.2. By Product & Services
        • 9.3.1.2.3. By Therapeutic Use
        • 9.3.1.2.4. By End User
    • 9.3.2. Argentina Clinical Trial Supplies Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Clinical Phase
        • 9.3.2.2.2. By Product & Services
        • 9.3.2.2.3. By Therapeutic Use
        • 9.3.2.2.4. By End User
    • 9.3.3. Colombia Clinical Trial Supplies Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Clinical Phase
        • 9.3.3.2.2. By Product & Services
        • 9.3.3.2.3. By Therapeutic Use
        • 9.3.3.2.4. By End User

10. Middle East and Africa Clinical Trial Supplies Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Clinical Phase
    • 10.2.2. By Product & Services
    • 10.2.3. By Therapeutic Use
    • 10.2.4. By End User
    • 10.2.5. By Country
  • 10.3. MEA: Country Analysis
    • 10.3.1. South Africa Clinical Trial Supplies Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Clinical Phase
        • 10.3.1.2.2. By Product & Services
        • 10.3.1.2.3. By Therapeutic Use
        • 10.3.1.2.4. By End User
    • 10.3.2. Saudi Arabia Clinical Trial Supplies Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Clinical Phase
        • 10.3.2.2.2. By Product & Services
        • 10.3.2.2.3. By Therapeutic Use
        • 10.3.2.2.4. By End User
    • 10.3.3. UAE Clinical Trial Supplies Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Clinical Phase
        • 10.3.3.2.2. By Product & Services
        • 10.3.3.2.3. By Therapeutic Use
        • 10.3.3.2.4. By End User

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Porters Five Forces Analysis

  • 13.1. Competition in the Industry
  • 13.2. Potential of New Entrants
  • 13.3. Power of Suppliers
  • 13.4. Power of Customers
  • 13.5. Threat of Substitute Products

14. Competitive Landscape

  • 14.1. Thermo Fisher Scientific Inc.
    • 14.1.1. Business Overview
    • 14.1.2. Company Snapshot
    • 14.1.3. Products & Services
    • 14.1.4. Financials (As Reported)
    • 14.1.5. Recent Developments
    • 14.1.6. Key Personnel Details
    • 14.1.7. SWOT Analysis
  • 14.2. Almac Group
  • 14.3. Novo Holdings A/S
  • 14.4. Marken (UPS)
  • 14.5. PCI Pharma Services
  • 14.6. Sharp Services LLC
  • 14.7. Cencora, Inc.
  • 14.8. Myonex
  • 14.9. Parexel International Corporation
  • 14.10. ICON Plc

15. Strategic Recommendations

16. About Us & Disclaimer